Skip to main content

Reconstruction of the Pathophysiology of Chronic Pain from Genome-wide Studies

Wednesday, December 1, 2021 - 3:00pm to 4:00pm


Luda Diatchenko, M.D., Ph.D.
Canada Excellence Research Chair in Human Pain Genetics
Pfizer Canada Professor in Pain Research
McGill University


The Diatchenko lab investigates the psychological, molecular, cellular, and genetic pathways that mediate both acute and persistent pain states. Their primary goal is to identify the critical elements of human genetic variability contributing to pain sensitivity and pathophysiological pain states that will enable individualized treatments and therapies. Other related research endeavors include molecular hierarchy of functional SNPs (single-nucleotide polymorphisms) and SNP-depend regulation of gene expression, underlying molecular pain signaling. Answering these questions requires collaboration with experts in both clinical and basic biological sciences. Such collaborative activities allow the Diatchenko group to take basic genetic findings all the way from human association studies, through molecular and cellular mechanisms, to animal models, and ultimately to human clinical trials.

The page was last updated on Friday, September 17, 2021 - 4:17pm